JW Pharmaceutical Corp (001065) — Working Capital to Net Assets Ratio
JW Pharmaceutical Corp (001065) has a Working Capital to Net Assets ratio of 31.6% as of September 2025. Working capital of ₩111.85 Billion (current assets of ₩331.96 Billion minus current liabilities of ₩220.10 Billion) is measured against net assets of ₩354.10 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 001065 net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
JW Pharmaceutical Corp Working Capital to Net Assets (2014–2024)
This chart shows how JW Pharmaceutical Corp's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 31.6%, reflecting working capital of ₩111.85 Billion against net assets of ₩354.10 Billion KRW. Check JW Pharmaceutical Corp tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for JW Pharmaceutical Corp (2014–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for JW Pharmaceutical Corp from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of JW Pharmaceutical Corp.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 29.7% | ₩97.80 Billion | ₩329.49 Billion | ₩306.41 Billion | ₩208.62 Billion | ▼ -4.7 pp |
| 2023 | 34.3% | ₩91.16 Billion | ₩265.44 Billion | ₩378.09 Billion | ₩286.93 Billion | ▲ +14.3 pp |
| 2022 | 20.1% | ₩45.33 Billion | ₩225.76 Billion | ₩425.46 Billion | ₩380.13 Billion | ▼ -24.4 pp |
| 2021 | 44.4% | ₩83.77 Billion | ₩188.54 Billion | ₩366.45 Billion | ₩282.68 Billion | ▲ +13.3 pp |
| 2020 | 31.1% | ₩64.58 Billion | ₩207.47 Billion | ₩299.33 Billion | ₩234.75 Billion | ▲ +6.3 pp |
| 2019 | 24.8% | ₩57.07 Billion | ₩230.09 Billion | ₩335.06 Billion | ₩277.98 Billion | ▼ -31.1 pp |
| 2018 | 56.0% | ₩145.54 Billion | ₩260.11 Billion | ₩373.91 Billion | ₩228.37 Billion | ▲ +5.4 pp |
| 2017 | 50.5% | ₩136.83 Billion | ₩270.78 Billion | ₩411.37 Billion | ₩274.54 Billion | ▼ -9.1 pp |
| 2016 | 59.6% | ₩164.67 Billion | ₩276.31 Billion | ₩422.64 Billion | ₩257.98 Billion | ▲ +8.4 pp |
| 2015 | 51.2% | ₩115.39 Billion | ₩225.41 Billion | ₩376.17 Billion | ₩260.78 Billion | ▼ -8.8 pp |
| 2014 | 60.0% | ₩132.06 Billion | ₩220.02 Billion | ₩343.50 Billion | ₩211.44 Billion | — |